公开(公告)号：US07803221B2

公开(公告)日：2010-09-28

申请号：US10569496

申请日：2004-08-24

Applicant: Shlomo Magdassi ,  Gera Eron ,  Yelena Vinetsky

Inventor： Shlomo Magdassi ,  Gera Eron ,  Yelena Vinetsky

IPC: C09D11/00 ,  C09D1/00 ,  C09D4/00 ,  C09D5/00 ,  C09K3/00 ,  C03C8/00

CPC classification number: C09D11/30 ,  B41J2/01 ,  B41J3/28 ,  B41J3/407 ,  B41J11/0015 ,  B41J11/002 ,  B41J11/0095 ,  B41M5/0047 ,  B41M5/007 ,  B41M7/0081 ,  B41M7/009

Abstract: The present invention concerns ink for printing on ceramic surfaces such as glass, which contains glass frits for silica nanoparticles and optionally a pigment, and is suitable for ink jet printing.

Abstract translation: 本发明涉及用于在诸如玻璃的陶瓷表面上印刷的油墨，其包含二氧化硅纳米颗粒和任选的颜料的玻璃料，并且适用于喷墨印刷。

公开(公告)号：US20080004436A1

公开(公告)日：2008-01-03

申请号：US11718929

申请日：2005-11-15

Applicant: Dan Tawfik ,  Kalia Bernath ,  Shlomo Magdassi ,  Sergio Peisajovich

Inventor： Dan Tawfik ,  Kalia Bernath ,  Shlomo Magdassi ,  Sergio Peisajovich

IPC: C07H21/00

CPC classification number: C12N15/1075

Abstract: The present invention is related to the field of compartmentalized libraries of genetic elements and the selection of biologically active molecules and the genes encoding same from said libraries. The selection assay of the invention utilizes water-in-oil emulsions and is particularly advantageous in applications in the field of directed-evolution, as exemplified herein for selection of protein inhibitors of DNA nucleases.

Abstract translation: 本发明涉及遗传元件的区室化文库领域以及生物活性分子的选择以及从所述文库编码相同的基因。 本发明的选择测定法使用油包水乳剂，并且在定向进化领域中的应用中是特别有利的，如本文所例示的用于选择DNA核酸酶的蛋白质抑制剂。

公开(公告)号：US06238650B1

公开(公告)日：2001-05-29

申请号：US09318828

申请日：1999-05-26

Applicant: Noa Lapidot ,  Shlomo Magdassi ,  David Avnir ,  Claudio Rottman ,  Orit Gans ,  Alon Seri-Levy

Inventor： Noa Lapidot ,  Shlomo Magdassi ,  David Avnir ,  Claudio Rottman ,  Orit Gans ,  Alon Seri-Levy

IPC: A61K742

CPC classification number: A61K8/042 ,  A61K8/11 ,  A61K8/25 ,  A61K8/35 ,  A61K8/37 ,  A61K8/40 ,  A61K8/445 ,  A61K2800/412 ,  A61Q17/04 ,  Y10S514/962

Abstract: The present invention generally relates to safe and stable sunscreen compositions comprising of at least one sunscreen active ingredient in the form of an inert sol-gel microcapsules encapsulating ultraviolet absorbing compounds in any acceptable cosmetic vehicle. The composition according to the present invention can comprise several ultraviolet absorbers that may be encapsulated in the same sol-gel microcapsule or in different capsules. The encapsulation of the ultraviolet absorbers reduces or even prevents the contact between the sunscreen compounds and the human tissue, thus reducing various adverse effects that are associated with the use of sunscreens, such as photoallergy and phototoxicity, and makes the composition safer for use. The encapsulation also reduces or even prevents cross reactivity between the sunscreen compounds and the packaging material and between the sunscreen compounds and any other component present in the composition, thus enhance the compositions stability. The hydophobicity/hydrophilicity character of the sol-gel microcapsules can be controlled by selecting suitable sol-gel precursors and suitable reaction conditions and can be chosen to be compatible with the cosmetic vehicle to be used in the sunscreen composition, thus, the present invention facilitates an easy incorporation of the composite sol-gel encapsulated sunscreen in all types of cosmetic vehicles including oil free compositions, with no necessary steps of heating or high shear forces. The sunscreen compositions of the present invention can comprise any acceptable UVA and/or UVB absorbing compounds at any desired ratio to obtain a desired accumulative ultraviolet screening spectrum.

Abstract translation: 本发明一般涉及安全和稳定的防晒组合物，其包含至少一种防霉活性成分，其形式为在任何可接受的化妆品载体中包封紫外线吸收化合物的惰性溶胶 - 凝胶微胶囊形式。 根据本发明的组合物可以包含几种可以包封在相同溶胶 - 凝胶微胶囊或不同胶囊中的紫外线吸收剂。 紫外线吸收剂的封装减少或甚至防止防晒化合物与人体组织之间的接触，从而减少与防晒剂的使用相关的各种不利影响，例如光过敏和光毒性，并使组合物更安全地使用。 封装还降低或甚至防止防晒化合物和包装材料之间以及防晒化合物和组合物中存在的任何其它组分之间的交叉反应性，从而增强组合物的稳定性。 可以通过选择合适的溶胶 - 凝胶前体和合适的反应条件来控制溶胶 - 凝胶微胶囊的疏水性/亲水性，并且可以选择与化妆品相容以用于防晒组合物，因此本发明有利于 将复合溶胶 - 凝胶包胶的防晒剂容易地并入包括无油组合物的所有类型的化妆品载体中，没有必要的加热步骤或高剪切力。 本发明的防晒组合物可以以任何所需的比例包含任何可接受的UVA和/或UVB吸收化合物，以获得所需的累积紫外线屏蔽谱。

公开(公告)号：US06037151A

公开(公告)日：2000-03-14

申请号：US954626

申请日：1997-10-20

Applicant: Aharon Meir Eyal ,  Sofia Kotlyar ,  Francoise Appelbaum ,  Shlomo Magdassi ,  Sergei Braun

Inventor： Aharon Meir Eyal ,  Sofia Kotlyar ,  Francoise Appelbaum ,  Shlomo Magdassi ,  Sergei Braun

IPC: C12P19/44 ,  C07H15/00

CPC classification number: C12P19/44

Abstract: The invention provides a process for the preparation of long-chain alkyl glycosides, comprising reacting a glucose-containing reactant and a C.sub.8 -C.sub.18 fatty alcohol in the presence of a glucosidase and a reaction promoter effective to promote the formation of the alkyl glycoside when the promoter is present in an amount of less than about 50 wt % of the total reaction mixture.

Abstract translation: 本发明提供了制备长链烷基糖苷的方法，包括在葡萄糖苷酶和反应促进剂存在下使含葡萄糖的反应物与C8-C18脂肪醇反应，所述反应促进剂有效促进烷基糖苷的形成 促进剂的存在量小于总反应混合物的约50重量％。

公开(公告)号：US5785969A

公开(公告)日：1998-07-28

申请号：US600988

申请日：1996-07-22

Applicant: Shlomo Magdassi ,  Zichria Zazkay Rones ,  Ofer Toledano

Inventor： Shlomo Magdassi ,  Zichria Zazkay Rones ,  Ofer Toledano

IPC: A61K47/48 ,  A61K49/00 ,  G01N33/543 ,  G01N33/569 ,  G01N33/94 ,  A61K39/395 ,  A61K47/44

CPC classification number: A61K49/0052 ,  A61K47/48038 ,  A61K47/48507 ,  A61K47/488 ,  A61K49/0043 ,  G01N33/5432 ,  G01N33/56966 ,  G01N33/94 ,  Y10S514/943 ,  Y10S977/808 ,  Y10S977/906 ,  Y10S977/918 ,  Y10S977/927

Abstract: The new pharmaceutical and diagnostic compositions comprise antibody-aggregates and hydrophobic drug or marker molecules. The drug or marker molecules are solubilized inside micelle-like antibody-aggregates. In a process for preparing such types of compositions, hydrophobic residues are attached to the antibodies in the presence of a surface active agent. After removal of this agent the hydrophobic drug or marker molecules are solubilized inside the resulting antibody aggregates. A method for targeting molecules towards specific cells and sites within a living body is also disclosed.

Abstract translation: PCT No.PCT / EP94 / 02827 Sec。 371日期：1996年7月22日 102（e）日期1996年7月22日PCT 1994年8月25日PCT公布。 公开号WO95 / 06483 日期1995年3月9日新的药物和诊断组合物包含抗体聚集体和疏水性药物或标记分子。 药物或标记分子溶解在胶束样抗体聚集体内。 在制备这种类型的组合物的方法中，疏水残基在表面活性剂存在下连接到抗体上。 除去该试剂后，疏水性药物或标记物分子溶解在所得抗体聚集体内。 还公开了将分子靶向生物体内的特定细胞和位点的方法。

公开(公告)号：US10064881B2

公开(公告)日：2018-09-04

申请号：US13992309

申请日：2011-12-08

Applicant: Tova Silberstein ,  Rachel Lutz ,  Shlomo Magdassi ,  Barak Tzadok

Inventor： Tova Silberstein ,  Rachel Lutz ,  Shlomo Magdassi ,  Barak Tzadok

IPC: A61K31/70 ,  A61K45/06 ,  A61K8/92 ,  A61K8/44 ,  A61K8/98 ,  A61Q5/02 ,  A61Q19/00 ,  A61K8/64 ,  A61K8/55 ,  A61K8/34 ,  A61K8/63 ,  A61K8/73 ,  A61K8/97 ,  A61K36/00 ,  A61Q11/00

Abstract: Provided is an all natural composition including naturally-obtained plant extracts.

公开(公告)号：US09107275B2

公开(公告)日：2015-08-11

申请号：US13503772

申请日：2010-11-02

Applicant: Shlomo Magdassi ,  Michael Grouchko ,  Michael Layani

Inventor： Shlomo Magdassi ,  Michael Grouchko ,  Michael Layani

IPC: H01L31/0224 ,  H05B33/28 ,  C23C4/18 ,  C23C26/00 ,  H01L31/18 ,  C23C16/513 ,  B05D3/10 ,  B05D5/06 ,  B05D5/12 ,  H01L33/42

CPC classification number: H05B33/28 ,  B05D3/107 ,  B05D5/061 ,  B05D5/12 ,  C23C4/18 ,  C23C16/513 ,  C23C26/00 ,  H01B1/02 ,  H01B1/026 ,  H01B1/10 ,  H01L31/022466 ,  H01L31/1884 ,  H01L33/42 ,  H01L2924/0002 ,  H01L2933/0016 ,  H05K1/0225 ,  H05K1/0278 ,  H05K1/0306 ,  H05K1/0313 ,  H05K1/0386 ,  H05K1/0393 ,  H05K1/092 ,  H05K1/095 ,  H05K1/097 ,  H05K3/125 ,  H05K3/14 ,  H05K2201/0257 ,  H05K2201/026 ,  H05K2201/0302 ,  H05K2201/0323 ,  H05K2201/0329 ,  H05K2201/0338 ,  H05K2201/035 ,  H05K2201/0391 ,  H05K2201/0969 ,  H05K2201/10053 ,  H05K2201/10106 ,  H05K2201/10151 ,  H05K2201/10166 ,  H05K2201/10174 ,  H05K2203/0545 ,  H05K2203/1173 ,  H05K2203/125 ,  Y02E10/50 ,  Y10T428/24273 ,  Y10T428/24331 ,  Y10T428/249978 ,  Y10T428/249979 ,  H01L2924/00

Abstract: The invention provides processes for the manufacture of conductive transparent films and electronic or optoelectronic devices comprising same.

Abstract translation: 本发明提供了用于制造导电透明膜的方法和包括其的电子或光电子器件。

公开(公告)号：US20120241693A1

公开(公告)日：2012-09-27

申请号：US13489032

申请日：2012-06-05

Applicant: Shlomo Magdassi ,  Alexander Kamyshny ,  Shai Aviezer ,  Michael Grouchko

Inventor： Shlomo Magdassi ,  Alexander Kamyshny ,  Shai Aviezer ,  Michael Grouchko

IPC: H01B1/02 ,  B82Y30/00

CPC classification number: B22F1/0022 ,  B22F1/0018 ,  B22F9/24 ,  B22F2998/00 ,  B82Y30/00 ,  C09D5/24 ,  C09D11/322 ,  C09D11/52 ,  C23C18/30 ,  Y10S977/773 ,  Y10S977/81

Abstract: The invention relates to a method for preparing an aqueous-based dispersion of metal nanoparticles comprising: (a) providing an aqueous suspension of a metal salt; (b) pre-reducing the metal salt suspension by a water soluble polymer capable of metal reduction to form a metal nuclei; and (c) adding a chemical reducer to form metal nanoparticles in dispersion. The invention further relates to aqueous-based dispersions of metal nanoparticles, and to compositions such as ink comprising such dispersions.

Abstract translation: 本发明涉及一种制备金属纳米颗粒的水性分散体的方法，包括：（a）提供金属盐的水性悬浮液; （b）通过能够金属还原的水溶性聚合物预还金属盐悬浮液以形成金属核; 和（c）添加化学还原剂以形成分散体中的金属纳米粒子。 本发明还涉及金属纳米颗粒的水基分散体，以及包含这种分散体的组合物如油墨。

公开(公告)号：US20120056341A1

公开(公告)日：2012-03-08

申请号：US13256040

申请日：2010-03-09

Applicant: Shlomo Magdassi ,  David Avnir ,  Liat Spernath

Inventor： Shlomo Magdassi ,  David Avnir ,  Liat Spernath

IPC: A61J3/07

CPC classification number: B01J13/16 ,  A61K8/11 ,  A61K9/5115 ,  A61K9/5192 ,  A61K2800/413 ,  C09B67/0097

Abstract: Silica nanocapsules are prepared from a nanoemulsions obtained by a phase inversion method.

Abstract translation: 二氧化硅纳米胶囊由通过相转化法获得的纳米乳剂制备。

公开(公告)号：US20110183128A1

公开(公告)日：2011-07-28

申请号：US13000415

申请日：2009-06-23

Applicant: Shlomo Magdassi ,  Michael Grouchko ,  Alexander Kamyshny

Inventor： Shlomo Magdassi ,  Michael Grouchko ,  Alexander Kamyshny

IPC: C09D11/02 ,  B32B3/10 ,  B05D5/00 ,  B05D3/02 ,  B05D3/10 ,  B82Y30/00

CPC classification number: B22F1/0022 ,  B01J13/02 ,  B22F1/0018 ,  B22F1/02 ,  B22F1/025 ,  B22F9/18 ,  B22F9/24 ,  B22F2001/0092 ,  B22F2301/10 ,  B22F2998/00 ,  B82Y30/00 ,  C09D11/30 ,  C09D11/322 ,  C09D11/52 ,  H05K1/097 ,  H05K2201/0218 ,  Y10T428/24901

Abstract: Provided is a composition including a plurality of multi-metallic nanoparticles each consisting essentially of a core including at least one first metal (Me1) and a continuous shell including atoms of at least one second metal (Me2). Optionally, the continuous shell of Me2 atoms protects the Me1 atoms from oxidation at all temperatures less than 150° C.

Abstract translation: 提供了包含多个多金属纳米颗粒的组合物，其各自主要由包含至少一种第一金属（Me1）的核和包含至少一种第二金属（Me 2）的原子的连续壳组成。 任选地，Me2原子的连续壳保护Me1原子在小于150℃的所有温度下的氧化。